25.11.2014 Views

PERCUTANEOUS MANIPULATIONS OF THE BILIARY TRACT

PERCUTANEOUS MANIPULATIONS OF THE BILIARY TRACT

PERCUTANEOUS MANIPULATIONS OF THE BILIARY TRACT

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Metal Stent Outcomes<br />

• Clinical success<br />

– Serum bilirubin decreases 63-100%<br />

• Quality of survival<br />

– Solves hydration and K + loss problems<br />

– Physiological antegrade bile flow<br />

– Shortens hospitalization time<br />

• Stent patency — 58 to 93% over 3 - 12 months<br />

• Reintervention rate decreased vs plastic<br />

• Nitinol (78%) better 6 mo patency than Z-<br />

stents (30%) and tantalum (20%)<br />

– (Rossi P, JVIR, 1994)<br />

Lee KH. et al. Biliary intervention for cholangiocarcinoma.<br />

Abdominal Imaging. 29(5):581-9, 2004 Sep-Oct.<br />

PTFE COVERED STENTS<br />

FOR MALIGNANT <strong>BILIARY</strong> OBSTRUCTION<br />

• Prospective multicenter safety and efficacy<br />

trial in Europe<br />

• 42 pts -- 38 unilateral - 4 bilateral stents<br />

• Technical success 100%<br />

• 4/42 (10%) branch obstruction<br />

• 2/42 (5%) complications<br />

– Entry site bile leak (1) and hematoma (1)<br />

– Only 1 mild case of lab pancreatitis (not complication)<br />

• 8/41 (20%) 30 day mortality - none biliary<br />

• Median primary patency 138 days<br />

• 6/41 (15%) obstruction mean 106 days<br />

• 3, 6,12 mo primary patency 90%, 76%, 76%<br />

– Schoder M et al, Radiol 2002; 225:35-42<br />

COVERED VS UNCOVERED STENTS<br />

DOES CANCER TYPE MATTER?<br />

• 73 patients with cancer<br />

– Covered stents (CS) 42, Uncovered stents (US) 31<br />

• Cholangio ca 12, gb ca 22, pancreas ca 12<br />

– 6 mo patency CS US<br />

• Overall 81% 50%<br />

– Mean time of patency CS US<br />

• Cholangio ca 15 mo 28 mo<br />

• Gb ca 13 mo 3 mo<br />

• Pancreas ca 12 mo 10 mo<br />

– Kawamoto H, Hepato-gastroenterology, 2005; 52(65): 1351-6<br />

IR Management of<br />

Liver Transplant Complications<br />

• Most recipients will have a complication<br />

– Arterial<br />

• Thrombosis 6.8% (high mortality)<br />

• Steal 5.9%<br />

– Portal 1.8%<br />

– Caval

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!